Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2026-06-26 @ 8:50 AM
Study NCT ID:
NCT05395533
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-25
First Post:
2022-05-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
Sponsor:
Zhejiang Teruisi Pharmaceutical Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | CD20-positive B-cell Non-Hodgkin Lymphoma | View |
Keywords: